Cardiometabolic Disease–Associated Markers Begin to Increase at an A1C >5%
AACE Endocrinology and Diabetes · 2026-08
DOI: 10.1016/j.aed.2026.07.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-08. Verfasst von Marc S. Penn und 7 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quest Diagnostics Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Quest Diagnostics Inc
Zitieren
APA
Penn, M. S., Winchester, T. B., Saghir, J., Koney, A., Latsko, M. S., Dixit, S. B., Eckel, R. H., & Saghir, M. (2026). Cardiometabolic Disease–Associated Markers Begin to Increase at an A1C >5%. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.07.019
Vancouver
Penn MS, Winchester TB, Saghir J, Koney A, Latsko MS, Dixit SB, et al. Cardiometabolic Disease–Associated Markers Begin to Increase at an A1C >5%. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.07.019
BibTeX
@article{Penn2026,
author = {Penn, Marc S. and Winchester, Trisha B. and Saghir, John and Koney, Ayorkor and Latsko, Maeson S. and Dixit, Sanjay B. and Eckel, Robert H. and Saghir, Mouris},
title = {Cardiometabolic Disease–Associated Markers Begin to Increase at an A1C >5%},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.07.019}
}
EUVIMED